Camela, Elisa, et al. “Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-ID Questionnaire”. Dermatology Practical & Conceptual, vol. 13, no. 3, July 2023, p. e2023177, https://doi.org/10.5826/dpc.1303a177.